|
|
|
Lipocine Inc. 
|
1.62 -0.03 (-0.02%) |
01-15 16:00 |
Open: |
1.67 |
Pre close: |
1.65 |
Target:
|
2.10
|
High: |
1.675 |
Low: |
1.56 |
Resistance:
|
1.80
2.10
|
Volume: |
1,822,127 |
Market Cap: |
106M |
Support:
|
1.46
1.25
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
1.62
 |
MACD |
MACD(12,26):
|
0.05  |
MA(20): |
1.46  |
Signal(12,26,9): |
0.02  |
MA(100): |
1.43  |
Stochastic Oscillator |
%K(14,3):
|
62.96  |
MA(250): |
1.11  |
%D(3): |
64.65  |
Average Volume(K) |
3-Month: |
251858
|
52-Week |
High:
|
2.39 |
10-Days: |
341150 |
Low: |
0.30 |
RSI |
RSI(14):
|
58.34  |
Change(%): |
194.5 |
Financials, Statistics and Valuation |
EPS |
-0.426 |
Return on Equity (ttm) |
-179.4 |
Shares Out. (M) |
65.69 |
EPS Est. Current Year |
-0.960 |
Return on Assets (ttm) |
-49.4 |
Shares Float (M) |
63.51 |
EPS Est. Next Year |
-0.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.31 |
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
10.99 |
Forward EPS |
-0.500 |
Gross Profit (p.s.) |
-0.077 |
Shares Short (K) |
4520 |
Book Value (p.s.) |
0.220 |
EBITDA (p.s.) |
-0.253 |
P/E |
-3.80 |
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
7.36 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.93 |
P/S |
0.00 |
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-8.66 |
P/CF |
-7.13 |
|
|
|
|
|